763105-70-0,
849832-73-1,
(Z)-2,2,2-trifluoro-N'-(piperazin-2-ylidene)acetohydrazide,
N-[(2Z)-Piperazin-2-ylidene]-2,2,2-trifluoroacetohydrazide,
acetic acid, 2,2,2-trifluoro-, (2z)-2-(2-piperazinylidene)hydrazide,
N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide,
2,2,2-Trifluoro-N'-(piperazin-2-ylidene)acetohydrazide,
RKIDLJBEMIARHI-UHFFFAOYSA-N,
Sitagliptin impurity 11,
C6H9F3N4O,
SCHEMBL2853721,
SCHEMBL18774234,
DTXSID50434513,
2,2,2-trifluoro-N'-[(2Z)-piperazin-2-ylidene]acetohydrazide,
CS-M0691,
2,2,2-trifluoro-N'-(3,4,5,6-tetrahydropyrazin-2-yl)acetohydrazide,
3894AH,
MFCD09833209,
ZINC22010516,
AKOS015966840,
AKOS030231499,
AC-8856,
ACN-028853,
KS-00001E80,
AK171176,
AS-34164,
AM20100749,
FT-0673927,
833T209,
Trifluoroacetic Acid (2Z)-Piperazinylidenehydrazide,
1-(Trifluoroacetyl)-2-(piperazine-2-ylidene)hydrazine,
N'-((Z)-piperazin-2-ylidene)-trifluoroacetohydrazide,
Trifluoro-acetic acid piperazin-(2z)-ylidene-hydrazide,
Acetic acid, trifluoro-, (2Z)-piperazinylidenehydrazide,
2,2,2-trifluoro-N'-(1,2,3,6-tetrahydropyrazin-5-yl)acetohydrazide,
CID10036009,
EC 616-320-4,
2,2,2-Trifluoro-N'-((2Z)-piperazin-2-ylidene)acetohydrazide,
2,2,2-trifluoro-N inverted exclamation mark -[(2Z)Piperazin -2-ylidene]acetohyroazide,